Dendritic-cell immunotherapy:: from ex vivo loading to in vivo targeting

被引:618
作者
Tacken, Paul J. [1 ]
de Vries, I. Jolanda M. [1 ]
Torensma, Ruurd [1 ]
Figdor, Carl G. [1 ]
机构
[1] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Med Ctr, NL-6500 HB Nijmegen, Netherlands
关键词
D O I
10.1038/nri2173
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The realization that dendritic cells (DCs) orchestrate innate and adaptive immune responses has stimulated research on harnessing DCs to create more effective vaccines. Early clinical trials exploring autologous DCs that were loaded with antigens ex vivo to induce T-cell responses have provided proof of principle. Here, we discuss how direct targeting of antigens to DC surface receptors in vivo might replace laborious and expensive ex vivo culturing, and facilitate large - scale application of DC-based vaccination therapies.
引用
收藏
页码:790 / 802
页数:13
相关论文
共 152 条
[61]   Antigenic targeting of the human mannose receptor induces tumor immunity [J].
He, Li-Zhen ;
Crocker, Andrea ;
Lee, Janine ;
Mendoza-Ramirez, Jose ;
Wang, Xi-Tao ;
Vitale, Laura A. ;
O'Neill, Thomas ;
Petromilli, Chris ;
Zhang, Hui-Fen ;
Lopez, Joe ;
Rohrer, Dan ;
Keler, Tibor ;
Clynes, Raphael .
JOURNAL OF IMMUNOLOGY, 2007, 178 (10) :6259-6267
[62]   A novel human cancer vaccine elicits cellular responses to the tumor-associated antigen, human chorionic gonadotropin β [J].
He, LZ ;
Ramakrishna, V ;
Connolly, JE ;
Wang, XT ;
Smith, PA ;
Jones, CL ;
Valkova-Valchanova, M ;
Arunakumari, A ;
Treml, JF ;
Goldstein, J ;
Wallace, PK ;
Keler, T ;
Endres, MJ .
CLINICAL CANCER RESEARCH, 2004, 10 (06) :1920-1927
[63]   An adenovirus vector with a chimeric fiber incorporating stabilized single chain antibody achieves targeted gene delivery [J].
Hedley, SJ ;
Maur, AAD ;
Hohn, S ;
Escher, D ;
Barberis, A ;
Glasgow, JN ;
Douglas, JT ;
Korokhov, N ;
Curiel, DT .
GENE THERAPY, 2006, 13 (01) :88-94
[64]   Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice [J].
Heijnen, IAFM ;
vanVugt, MJ ;
Fanger, NA ;
Graziano, RF ;
deWit, TPM ;
Hofhuis, FMA ;
Guyre, PM ;
Capel, PJA ;
Verbeek, JS ;
vandeWinkel, JGJ .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (02) :331-338
[65]   Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors [J].
Heiser, A ;
Coleman, D ;
Dannull, J ;
Yancey, D ;
Maurice, MA ;
Lallas, CD ;
Dahm, P ;
Niedzwiecki, D ;
Gilboa, E ;
Vieweg, J .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (03) :409-417
[66]   Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages [J].
Herre, J ;
Marshall, ASJ ;
Caron, E ;
Edwards, AD ;
Williams, DL ;
Schweighoffer, E ;
Tybulewicz, V ;
Sousa, CRE ;
Gordon, S ;
Brown, GD .
BLOOD, 2004, 104 (13) :4038-4045
[67]   Immunotherapy of patients with hormone-refractory prostate carcinoma pre-treated with interferon-gamma and vaccinated with autologous PSA-peptide loaded dendritic cells -: A pilot study [J].
Hildenbrand, B. ;
Sauer, B. ;
Kalis, O. ;
Stoll, C. ;
Freudenberg, M. A. ;
Niedermann, G. ;
Giesler, J. M. ;
Juettner, E. ;
Peters, J. H. ;
Haering, B. ;
Leo, R. ;
Unger, C. ;
Azemar, M. .
PROSTATE, 2007, 67 (05) :500-508
[68]   Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamide [J].
Höltl, L ;
Ramoner, R ;
Zelle-Rieser, C ;
Gander, H ;
Putz, T ;
Papesh, C ;
Nussbaumer, W ;
Falkensammer, C ;
Bartsch, G ;
Thurnher, M .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2005, 54 (07) :663-670
[69]  
Höltl L, 2002, CLIN CANCER RES, V8, P3369
[70]   Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells [J].
Höltl, L ;
Rieser, C ;
Papesh, C ;
Ramoner, R ;
Herold, M ;
Klocker, H ;
Radmayr, C ;
Stenzl, A ;
Bartsch, G ;
Thurnher, M .
JOURNAL OF UROLOGY, 1999, 161 (03) :777-782